Adaptive Biotechnologies (ADPT) Interest Coverage Ratio (2022 - 2026)
Adaptive Biotechnologies' (ADPT) quarterly Interest Coverage Ratio came in at 6.65 in Q1 2026, up 34.76% year-on-year from 4.93 in Q1 2025, and down 53.75% quarter-over-quarter from 4.32 in Q4 2025.
Adaptive Biotechnologies (ADPT) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Adaptive Biotechnologies has disclosed Interest Coverage Ratio across 5 years of filings, most recently posting 6.65 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 6.65, up 34.76% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.97 (up 68.16% YoY), and the FY2025 annual result was 4.85, up 65.45% from the prior year.
- Interest Coverage Ratio came in at 6.65 for Q1 2026 at Adaptive Biotechnologies, down from 4.32 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 3.46 in Q3 2025 to a low of 69.57 in Q3 2022.
- The 5-year median for Interest Coverage Ratio is 11.46 (2024), against an average of 15.34.
- Across the five-year window, Interest Coverage Ratio plunged 115.86% in 2023 and jumped 131.19% in 2025, its largest moves.
- Adaptive Biotechnologies' Interest Coverage Ratio stood at 10.93 in 2022, then plunged by 115.86% to 23.59 in 2023, then jumped by 51.42% to 11.46 in 2024, then jumped by 62.28% to 4.32 in 2025, then slumped by 53.75% to 6.65 in 2026.
- The last three Interest Coverage Ratio figures came in at 6.65 (Q1 2026), 4.32 (Q4 2025), and 3.46 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -0.98 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 5.26 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 21.33 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 46.84 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 15.96 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -104.84 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 2.68 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 8.71 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 14.05 |
| 10 | Adaptive Biotechnologies | 2.71 Bn | 2.50 Bn | 52.17 Mn | -6.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.65 |
| Dec 31, 2025 | -4.32 |
| Sep 30, 2025 | 3.46 |
| Jun 30, 2025 | -8.49 |
| Mar 31, 2025 | -10.19 |
| Dec 31, 2024 | -11.46 |
| Sep 30, 2024 | -11.10 |
| Jun 30, 2024 | -17.55 |
| Mar 31, 2024 | -16.29 |
| Dec 31, 2023 | -23.59 |
| Sep 30, 2023 | -13.95 |
| Jun 30, 2023 | -13.26 |
| Mar 31, 2023 | -16.20 |
| Dec 31, 2022 | -10.93 |
| Sep 30, 2022 | -69.57 |